News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Altea Therapeutics Announces Senior R&D Management Appointments to Align Product Development with Needs of Commercialization Partners


5/5/2009 9:40:39 AM

ATLANTA--(BUSINESS WIRE)--Altea Therapeutics, a leader in advanced transdermal drug delivery systems, announced today senior R&D appointments to strengthen its product development and commercialization capabilities and to align technical operations with the needs of its alliance partners, including Amylin Pharmaceuticals Inc., Eli Lilly and Company, and Hospira, Inc.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES